NCT01155700 - Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Omalizumab in Japanese Children (6 - 15 Years) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions

Allergic Asthma

Interventions

DRUG

omalizumab

Trial Locations (17)

474-0031

Novartis Investigative Site, Ohbu

266-0007

Novartis Investigative Site, Chiba

811-1394

Novartis Investigative Site, Fukuoka

501-1194

Novartis Investigative Site, Gifu

228-8522

Novartis Investigative Site, Sagamihara

232-8555

Novartis Investigative Site, Yokohama

245-8575

Novartis Investigative Site, Yokohama

514-0125

Novartis Investigative Site, Tsu

632-8552

Novartis Investigative Site, Tenri

583-8588

Novartis Investigative Site, Habikino

530-0012

Novartis Investigative Site, Osaka

321-0293

Novartis Investigative Site, Shimotsuka-gun

183-8561

Novartis Investigative Site, Fuchū

201-8601

Novartis Investigative Site, Komae

157-8535

Novartis Investigative Site, Setagaya-ku

158-0097

Novartis Investigative Site, Setagaya-ku

130-8587

Novartis Investigative Site, Sumida-ku